BRD2 and invasive breast carcinoma: In the BRCA group as a whole, more FSH was administered per obtained mature oocyte when compared to the control group (median FSH/mature oocyte ratios 353.0 (IQR 210.7–521.9) and 250.0 (IQR 168.6–375.0), respectively, p = 0.03).